Progress in PBC: Seladelpar in Trial as Second-Line Therapy
Gastroenterology Learning Network
00:00
Safety and Benefits of Cello del Par as a Treatment for Primary Biliary Cholangitis
This chapter discusses the safety of cello del par as a treatment for primary biliary cholangitis (PBC), highlighting that the drug appears to be very safe based on current data. It mentions ongoing safety studies and expresses confidence in its appropriate safety signal.
Transcript
Play full episode
